Announcements Trials

Browse Landscape

Phase

Phase 4 2 Phase 3 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Stomach Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Rectal Neoplasms 1 Pancreatic Neoplasms 1 Neoplasms 1 Neoplasm Metastasis 1 Lung Neoplasms 1 Liver Neoplasms 1 Gallbladder Neoplasms 1 Fatigue 1 Esophageal Neoplasms 1 ENT Cancer 1 Depressive Disorder, Major 1 Depression 1 Colorectal Neoplasms 1 Colonic Neoplasms 1 Carcinoma, Non-Small-Cell Lung 1 Carcinoma 1 Breast Neoplasms 1 Bile Duct Neoplasms 1

Interventions

Interpersonal Psychotherapy 1 Escitalopram 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Depressive Disorder, Major × Escitalopram × Clear all

NCT04973930 2025-05-13

IPT

New York State Psychiatric Institute

Phase 3 Suspended

Breast Neoplasms, Depressive Disorder, Major

Data powered by HemOnc (CC BY 4.0) Colophon ⚡